Search

Your search keyword '"Paluch-Shimon S"' showing total 227 results
Start Over Author "Paluch-Shimon S"
227 results on '"Paluch-Shimon S"'

1. Palliative care: needs of advanced breast cancer patients

Author

Cherny NI, Paluch-Shimon S, and Berner-Wygoda Y

Subjects
Breast cancer, palliative care, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Nathan I Cherny, Shani Paluch-Shimon, Yael Berner-Wygoda Integrated Oncology and Palliative Medicine Department, Breast Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Israel Abstract: Advanced breast cancer is characterized by many physical manifestations with the potential to undermine the quality of life (most related to the cancer and some to treatments), as well as substantial impact on psychosocial well-being. Patients with advanced breast cancer and their families have complex needs that have to be addressed in order to minimize severe distress and deterioration in the quality of life of patients and their family members. This task requires the full engagement of an interdisciplinary approach to palliative care with strong emphasis on the assessment of needs and anticipated needs, patient expectations, skilled therapeutics, and commitment to continuity of care. In this review, we address four issues: 1) organizational and conceptual issues in palliative care of patients with breast cancer, 2) common physical symptoms among patients with breast cancer and their management, 3) common psychological issues among patients with breast cancer, and 4) common challenging palliative care problems in breast cancer. Keywords: psychooncology, supportive care, goal setting, quality of life

Published
2018

2. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Author

Arecco, L., Bruzzone, M., Bas, R., Kim, H.J., Di Meglio, A., Bernstein-Molho, R., Hilbers, F.S., Pogoda, K., Carrasco, E., Punie, K., Bajpai, J., Agostinetto, E., Lopetegui-Lia, N., Partridge, A.H., Phillips, K.A., Toss, A., Rousset-Jablonski, C., Curigliano, G., Renaud, T., Ferrari, A., Paluch-Shimon, S., Fruscio, R., Cui, W., Wong, S.M., Vernieri, C., Couch, F.J., Dieci, M.V., Matikas, A., Rozenblit, M., Aguilar-y Méndez, D., De Marchis, L., Puglisi, F., Fabi, A., Graff, S.L., Witzel, I., Rodriguez Hernandez, A., Fontana, A., Pesce, R., Duchnowska, R., Pais, H.L., Sini, V., Sokolović, E., de Azambuja, E., Ceppi, M., Blondeaux, E., and Lambertini, M.

Published
2024
Full Text
View/download PDF

3. Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3

Author

Goetz, M.P., Toi, M., Huober, J., Sohn, J., Trédan, O., Park, I.H., Campone, M., Chen, S.-C., Manso, L.M., Paluch-Shimon, S., Freedman, O.C., O’Shaughnessy, J., Pivot, X., Tolaney, S.M., Hurvitz, S.A., Llombart-Cussac, A., André, V., Saha, A., van Hal, G., Shahir, A., Iwata, H., and Johnston, S.R.D.

Published
2024
Full Text
View/download PDF

4. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Author

Loibl, S., André, F., Bachelot, T., Barrios, C.H., Bergh, J., Burstein, H.J., Cardoso, M.J., Carey, L.A., Dawood, S., Del Mastro, L., Denkert, C., Fallenberg, E.M., Francis, P.A., Gamal-Eldin, H., Gelmon, K., Geyer, C.E., Gnant, M., Guarneri, V., Gupta, S., Kim, S.B., Krug, D., Martin, M., Meattini, I., Morrow, M., Janni, W., Paluch-Shimon, S., Partridge, A., Poortmans, P., Pusztai, L., Regan, M.M., Sparano, J., Spanic, T., Swain, S., Tjulandin, S., Toi, M., Trapani, D., Tutt, A., Xu, B., Curigliano, G., and Harbeck, N.

Published
2024
Full Text
View/download PDF

5. Pregnancy after Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study

Author

Lambertini, M, Blondeaux, E, Agostinetto, E, Hamy, A, Kim, H, Di Meglio, A, Bernstein Molho, R, Hilbers, F, Pogoda, K, Carrasco, E, Punie, K, Bajpai, J, Ignatiadis, M, Moore, H, Phillips, K, Toss, A, Rousset-Jablonski, C, Peccatori, F, Renaud, T, Ferrari, A, Paluch-Shimon, S, Fruscio, R, Cui, W, Wong, S, Vernieri, C, Ruddy, K, Dieci, M, Matikas, A, Rozenblit, M, Villarreal-Garza, C, De Marchis, L, Del Mastro, L, Puglisi, F, Del Pilar Estevez-Diz, M, Rodriguez-Wallberg, K, Mrinakova, B, Meister, S, Livraghi, L, Clatot, F, Yerushalmi, R, De Angelis, C, Sánchez-Bayona, R, Meattini, I, Cichowska-Cwalińska, N, Berlière, M, Salama, M, De Giorgi, U, Sonnenblick, A, Chiodi, C, Lee, Y, Maria, C, Azim, H, Boni, L, Partridge, A, Lambertini M., Blondeaux E., Agostinetto E., Hamy A. S., Kim H. J., Di Meglio A., Bernstein Molho R., Hilbers F., Pogoda K., Carrasco E., Punie K., Bajpai J., Ignatiadis M., Moore H. C. F., Phillips K. A., Toss A., Rousset-Jablonski C., Peccatori F. A., Renaud T., Ferrari A., Paluch-Shimon S., Fruscio R., Cui W., Wong S. M., Vernieri C., Ruddy K. J., Dieci M. V., Matikas A., Rozenblit M., Villarreal-Garza C., De Marchis L., Del Mastro L., Puglisi F., Del Pilar Estevez-Diz M., Rodriguez-Wallberg K. A., Mrinakova B., Meister S., Livraghi L., Clatot F., Yerushalmi R., De Angelis C., Sánchez-Bayona R., Meattini I., Cichowska-Cwalińska N., Berlière M., Salama M., De Giorgi U., Sonnenblick A., Chiodi C., Lee Y. J., Maria C., Azim H. A., Boni L., Partridge A. H., Lambertini, M, Blondeaux, E, Agostinetto, E, Hamy, A, Kim, H, Di Meglio, A, Bernstein Molho, R, Hilbers, F, Pogoda, K, Carrasco, E, Punie, K, Bajpai, J, Ignatiadis, M, Moore, H, Phillips, K, Toss, A, Rousset-Jablonski, C, Peccatori, F, Renaud, T, Ferrari, A, Paluch-Shimon, S, Fruscio, R, Cui, W, Wong, S, Vernieri, C, Ruddy, K, Dieci, M, Matikas, A, Rozenblit, M, Villarreal-Garza, C, De Marchis, L, Del Mastro, L, Puglisi, F, Del Pilar Estevez-Diz, M, Rodriguez-Wallberg, K, Mrinakova, B, Meister, S, Livraghi, L, Clatot, F, Yerushalmi, R, De Angelis, C, Sánchez-Bayona, R, Meattini, I, Cichowska-Cwalińska, N, Berlière, M, Salama, M, De Giorgi, U, Sonnenblick, A, Chiodi, C, Lee, Y, Maria, C, Azim, H, Boni, L, Partridge, A, Lambertini M., Blondeaux E., Agostinetto E., Hamy A. S., Kim H. J., Di Meglio A., Bernstein Molho R., Hilbers F., Pogoda K., Carrasco E., Punie K., Bajpai J., Ignatiadis M., Moore H. C. F., Phillips K. A., Toss A., Rousset-Jablonski C., Peccatori F. A., Renaud T., Ferrari A., Paluch-Shimon S., Fruscio R., Cui W., Wong S. M., Vernieri C., Ruddy K. J., Dieci M. V., Matikas A., Rozenblit M., Villarreal-Garza C., De Marchis L., Del Mastro L., Puglisi F., Del Pilar Estevez-Diz M., Rodriguez-Wallberg K. A., Mrinakova B., Meister S., Livraghi L., Clatot F., Yerushalmi R., De Angelis C., Sánchez-Bayona R., Meattini I., Cichowska-Cwalińska N., Berlière M., Salama M., De Giorgi U., Sonnenblick A., Chiodi C., Lee Y. J., Maria C., Azim H. A., Boni L., and Partridge A. H.

Abstract

Importance: Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy in breast cancer survivors included limited data regarding BRCA carriers. Objective: To investigate cumulative incidence of pregnancy and disease-free survival in young women who are BRCA carriers. Design, setting, and participants: International, multicenter, hospital-based, retrospective cohort study conducted at 78 participating centers worldwide. The study included female participants diagnosed with invasive breast cancer at age 40 years or younger between January 2000 and December 2020 carrying germline pathogenic variants in BRCA1 and/or BRCA2. Last delivery was October 7, 2022; last follow-up was February 20, 2023. Exposure: Pregnancy after breast cancer. Main outcomes and measures: Primary end points were cumulative incidence of pregnancy after breast cancer and disease-free survival. Secondary end points were breast cancer-specific survival, overall survival, pregnancy, and fetal and obstetric outcomes. Results: Of 4732 BRCA carriers included, 659 had at least 1 pregnancy after breast cancer and 4073 did not. Median age at diagnosis in the overall cohort was 35 years (IQR, 31-38 years). Cumulative incidence of pregnancy at 10 years was 22% (95% CI, 21%-24%), with a median time from breast cancer diagnosis to conception of 3.5 years (IQR, 2.2-5.3 years). Among the 659 patients who had a pregnancy, 45 (6.9%) and 63 (9.7%) had an induced abortion or a miscarriage, respectively. Of the 517 patients (79.7%) with a completed pregnancy, 406 (91.0%) delivered at term (≥37 weeks) and 54 (10.4%) had twins. Among the 470 infants born with known information on pregnancy complications, 4 (0.9%) had documented congenital anomalies. Median follow-up was 7.8 years (IQR, 4.5-12.6 years). No significant difference in disease-free survival was observed between patie

Published
2024

6. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force

Author

Razis, E., Escudero, M.J., Palmieri, C., Mueller, V., Bartsch, R., Rossi, G., Gampenrieder, S.P., Kolberg, H.C., Zdenkowski, N., Pavic, M., Connolly, R.M., Rosset, L., Arcuri, J., Tesch, H., Vallejos, C., Retamales, J., Musolino, A., Del Mastro, L., Christodoulou, C., Aebi, S., Paluch-Shimon, S., Gupta, S., Ohno, S., Macpherson, I., Ekholm, M., Zaman, K., Vidal, M., Chakiba, C., Fumagalli, D., Thulin, A., Witzel, I., Kotecki, N., Gil-Gil, M., and Linderholm, B.

Published
2022
Full Text
View/download PDF

7. Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

Author

Condorelli, M., Bruzzone, M., Ceppi, M., Ferrari, A., Grinshpun, A., Hamy, A.S., de Azambuja, E., Carrasco, E., Peccatori, F.A., Di Meglio, A., Paluch-Shimon, S., Poorvu, P.D., Venturelli, M., Rousset-Jablonski, C., Senechal, C., Livraghi, L., Ponzone, R., De Marchis, L., Pogoda, K., Sonnenblick, A., Villarreal-Garza, C., Córdoba, O., Teixeira, L., Clatot, F., Punie, K., Graffeo, R., Dieci, M.V., Pérez-Fidalgo, J.A., Duhoux, F.P., Puglisi, F., Ferreira, A.R., Blondeaux, E., Peretz-Yablonski, T., Caron, O., Saule, C., Ameye, L., Balmaña, J., Partridge, A.H., Azim, H.A., Demeestere, I., and Lambertini, M.

Published
2021
Full Text
View/download PDF

8. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

Author

Bachelot, T., Bouzid, K., Campone, M., Desmoulins, I., Coudert, B., Bondarenko, I., Nowecki, Z., Glogowska, I., Ciruelos Gil, E., Errihani, H., Dalenc, F., Ricci, F., Dieras, V., Kaufman, B., Paluch-Shimon, S., Wardley, A., Schneeweiss, A., Ferreira, A., Mano, M., Kalofonos, H., Andreetta, C., Puglisi, F., Montemurro, F., Barrett, S., Zhang, Q., Mavroudis, D., Matus, J., Villarreal Garza, C., Beato, C., Ismael, G., Hu, X., Abdel Azeem, H., Gaafar, R., Perrin, C., Kerbrat, P., Ettl, J., Paepke, S., Hitre, E., Lang, I., Trudeau, M., Verma, S., Li, H., Hoffmann, O., Aktas, B., Cariello, A., Cruciani, G., Tienghi, A., Tondini, C., Al-Twegieri, T., Loman, N., Laing, R., Miles, D., Brain, E., Fasching, P., Lux, M., Frassoldati, A., Aziz, Z., Salas, J., Streb, J., Krzemieniecki, K., Wronski, A., Garcia Garcia, J., Menjon Beltran, S., Cicin, I., Schmid, P., Gallagher, C., Turner, N., Tong, Z., Boer, K., Juhász, B., Horvath, Z., Bianchini, G., Gianni, L., Curigliano, G., Juarez Ramiro, A., Susnjar, S., Matos, E., Sevillano, E., Garcia Estevez, L., Gokmen, E., Uslu, R., Wildiers, H., Schutz, F., Cruz, M., Bourgeois, H., von Schumann, R., Stemmer, S., Dominguez, A., Morales-Vásques, F., Wojtukiewicz, M., Trifunovic, J., Echarri Gonzalez, M.J., Illarramendi Mañas, J., Martinez De Dueñas, E., Voitko, N., Hicks, J., Waters, S., Barrett-Lee, P., Wheatley, D., De Boer, R., Cocquyt, V., Jerusalem, G., Barrios, C., Panasci, L., Mattson, J., Tanner, M., Gozy, M., Vasilopoulos, G., Papandreou, C., Revesz, J., Battelli, N., Benedetti, G., Latini, L., Gridelli, C., Lazaro Leon, J., Alarcón Company, J., Arance Fernandez, A., Barnadas Molins, A., Calvo Plaza, I., Bratos, R., Gonzalez Martin, A., Izarzugaza Peron, Y., Klint, L., Kovalev, A., McCarthy, N., Yeo, B., Kee, D., Thomson, J., White, S., Greil, R., Wang, S., Artignan, X., Juhasz-Böess, I., Rody, A., Ngan, R., Dourleshter, F., Goldberg, H., Doni, L., Di Costanzo, F., Ferraù, F., Drobniene, M., Aleknavicius, E., Rashid, K., Costa, L., de la Cruz Merino, L., Garcia Saenz, J., López, R., Del Val Munoz, O., Ozyilkan, O., Azribi, F., Jaafar, H., Baird, R., Verrill, M., Beith, J., Petzer, A., Moreira de Andrade, J., Bernstein, V., Macpherson, N., Rayson, D., Saad Eldin, I., Achille, M., Augereau, P., Müller, V., Rasco, A., Evron, E., Katz, D., Berardi, R., Cascinu, S., De Censi, A., Gennari, A., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Van den Bosch, J., Kukulska, M., Kalinka, E., Alonso, J., Dalmau Portulas, E., Del Mar Gordon Santiago, M., Pelaez Fernandez, I., Aksoy, S., Altundag, K., Senol Coskun, H., Bozcuk, H., Shparyk, Y., Barraclough, L., Levitt, N., Panwar, U., Kelly, S., Rigg, A., Varughese, M., Castillo, C., Fein, L., Malik, L., Stuart-Harris, R., Singer, C., Stoeger, H., Samonigg, H., Feng, J., Cedeño, M., Ruohola, J., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Grischke, E.-M., Simon, E., Wagner, S., Koumakis, G., Papazisis, K., Ben Baruch, N., Fried, G., Geffen, D., Karminsky, N., Peretz, T., Cavanna, L., Pedrazzioli, P., Grasso, D., Ruggeri, E., D’Auria, G., Moscetti, L., Juozaityte, E., Rodriguez Cid, J., Roerdink, H., Siddiqi, N., Passos Coelho, J., Arcediano Del Amo, A., Garcia Garre, E., García Gonzalez, M., Garcia-Palomo Perez, A., Herenandez Perez, C., Lopez Alvarez, P., Lopez De Ceballos, M.H., Martínez Jañez, N., Mele Olive, M., McAdam, K., Perren, T., Dunn, G., Humphreys, A., Taylor, W., Vera, R., Kaen, L., Andel, J., Steger, G., De Grève, J., Huizing, M., Hegg, R., Joy, A., Kuruvilla, P., Sehdev, S., Smiljanic, S., Kütner, R., Alexandre, J., Grosjean, J., Laplaige, P., Largillier, R., Maes, P., Martin, P., Pottier, V., Christensen, B., Khandan, F., Lück, H.-J., Zahm, D.-M., Fountzilas, G., Karavasilis, V., Safra, T., Inbar, M., Ryvo, L., Bonetti, A., Seles, E., Giacobino, A., Chavarri Guerra, Y., de Jongh, F., van der Velden, A., van Warmerdam, L., Vrijaldenhoven, S., Smorenburg, C.H., Cavero, M., Andres Conejero, R., Oltra Ferrando, A., Redondo Sanchez, A., Ribelles Entrena, N., Saura Grau, S., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Butt, M., Joffe, J., Poole, C., Woodings, P., Chakraborti, P., Yordi, G., Woodward, N., Nobre, A., Luiz Amorim, G., Califaretti, N., Fox, S., Robidoux, A., Li, E., Li, N., Jiang, J., Soria, T., Padrik, P., Lahdenpera, O., Barletta, H., Dohollou, N., Genet, D., Prulhiere, K., Coeffic, D., Facchini, T., Vieillot, S., Catala, S., Teixeira, L., Hesse, T., Kühn, T., Ober, A., Repp, R., Schröder, W., Pectasides, D., Bodoky, G., Kahan, Z., Jiveliouk, I., Rosengarten, O., Rossi, V., Alabiso, O., Pérez Martínez, M., van de Wouw, A.J., Smok-Kalwat, J., Damasecno, M., Augusto, I., Sousa, G., Saadein, A., Abdelhafiez, N., Abulkhair, O., Antón Torres, A., Corbellas Aparicio, M., Llorente Domenech, R., Florián Jerico, J., Garcia Mata, J., Gil Raga, M., Galan Brotons, A., Llombart Cussac, A., Llorca Ferrandiz, C., Martinez Del Prado, P., Olier Garate, C., Rodriguez Sanchez, C., Sanchez Gomez, R., Santisteban Eslava, M., Soberino, J., Vidal Losada Garcia, M., Soto de Prado, D., Torrego Garcia, J., Vicente Rubio, E., Garcia, M., Murias Rosales, A., Granstam Björneklett, H., Narbe, U., Jafri, M., Rea, D., Newby, J., Jones, A., Westwell, S., Ring, A., Alonso, I., Rodríguez, R., Ciruelos, E., Peretz-Yablonski, T., Merot, J.-L., Trask, P., du Toit, Y., Pena-Murillo, C., Revelant, V., and Klingbiel, D.

Published
2021
Full Text
View/download PDF

9. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Author

Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M.S., André, F., Barrios, C.H., Bergh, J., Bhattacharyya, G.S., Biganzoli, L., Boyle, F., Cardoso, M.-J., Carey, L.A., Cortés, J., El Saghir, N.S., Elzayat, M., Eniu, A., Fallowfield, L., Francis, P.A., Gelmon, K., Gligorov, J., Haidinger, R., Harbeck, N., Hu, X., Kaufman, B., Kaur, R., Kiely, B.E., Kim, S.-B., Lin, N.U., Mertz, S.A., Neciosup, S., Offersen, B.V., Ohno, S., Pagani, O., Prat, A., Penault-Llorca, F., Rugo, H.S., Sledge, G.W., Thomssen, C., Vorobiof, D.A., Wiseman, T., Xu, B., Norton, L., Costa, A., and Winer, E.P.

Published
2020
Full Text
View/download PDF

12. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline ☆

Author

Sessa, C, Balmana, J, Bober, S, Cardoso, M, Colombo, N, Curigliano, G, Domchek, S, Evans, D, Fischerova, D, Harbeck, N, Kuhl, C, Lemley, B, Levy-Lahad, E, Lambertini, M, Ledermann, J, Loibl, S, Phillips, K, Paluch-Shimon, S, Sessa C., Balmana J., Bober S. L., Cardoso M. J., Colombo N., Curigliano G., Domchek S. M., Evans D. G., Fischerova D., Harbeck N., Kuhl C., Lemley B., Levy-Lahad E., Lambertini M., Ledermann J. A., Loibl S., Phillips K. -A., Paluch-Shimon S., Sessa, C, Balmana, J, Bober, S, Cardoso, M, Colombo, N, Curigliano, G, Domchek, S, Evans, D, Fischerova, D, Harbeck, N, Kuhl, C, Lemley, B, Levy-Lahad, E, Lambertini, M, Ledermann, J, Loibl, S, Phillips, K, Paluch-Shimon, S, Sessa C., Balmana J., Bober S. L., Cardoso M. J., Colombo N., Curigliano G., Domchek S. M., Evans D. G., Fischerova D., Harbeck N., Kuhl C., Lemley B., Levy-Lahad E., Lambertini M., Ledermann J. A., Loibl S., Phillips K. -A., and Paluch-Shimon S.

Published
2023

13. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Author

Bouzid, Kamel, Campone, Mario, Coudert, Bruno, Nowecki, Zbigniew, Errihani, Hassan, Dalenc, Florence, Ferreira, Ana, Mano, Max, Ricci, Francesco, Kalofonos, Haralabos, Andreetta, Claudia, Montemurro, Filippo, Barrett, Sophie, Zhang, Qingyuan, Mavroudis, Dimitris, Matus, Juan, Beato, Carlos, Hu, Xichun, Gaafar, Rabab, Abdel Azeem, Hamdy, Perrin, Christophe, Ettl, Johannes, Lang, Istvan, Verma, Sunil, Li, Huiping, Brain, Etienne, Hoffmann, Oliver, Cariello, Anna, Tondini, Carlo, Altwegeiri, Taher, Loman, Niklas, Lux, Michael, Frassoldati, Antonio, Aziz, Zeba, Salas, Fernando, Streb, Joanna, Wronski, Andrzej, Menjón Beltrán, Salomón, Cicin, Irfan, Schmid, Peter, Laing, Robert, Tong, Zhongsheng, Boer, Katalin, Juhasz, Balazs, Gianni, Luca, Curigliano, Giuseppe, Juarez, Alejandro, Susnjar, Snezana, Matos, Erika, Uslu, Ruchan, Wildiers, Hans, Cruz, Marcelo, Bourgeois, Hugues, von Schumann, Raquel, Stemmer, Salomón, Vásquez, Flavia Morales, Dominguez, Adriana, Wojtukiewicz, Marek, Trifunovic, Jasna, Illarramendi, Jose Juan, Garcia, Laura, Peron, Yann Izarzugaza, Echarri, Maria Jose, Voitko, Natliia, Wheatley, Duncan, Waters, Simon, De Boer, Richard, Jerusalem, Guy, Cocquyt, Véronique, Barrios, Carlos, Panasci, Lawrence, Mattson, Johanna, Tanner, Minna, Gozy, Michel, Vasilopoulos, Georgios, Revesz, Janos, Latini, Luciano, Gridelli, Cesare, Lazaro, Jesus, Gonzalez, Antonio, Barnadas Molins, Agusti, Martinez, Eduardo, Alarcón, Jesús, Arance, Ana, Klint, Leif, Kovalyov, Oleksiy, Baird, Richard, Yeo, Belinda, McCarthy, Nicole, Greil, Richard, Wang, Shusen, Artignan, Xavier, Augereau, Paule, Juhasz-Boess, Ingolf, Ngan, Roger, Goldberg, Hadassah, Di Costanzo, Francesco, Ferraù, Francesco, Aleknavicius, Eduardas, Rashid, Kamran, Costa, Luís, Angel Garcia, Jose, de la Cruz, Luis Ruiz, López López, Rafael, Del Val, Olga, Ozyilkan, Ozgur, Azribi, Fathi, Verrill, Mark, Turner, Nicholas, Beith, Jane, Petzer, Andreas, Andrade, Jurandyr, Bernstein, Vanessa, Rayson, Daniel, Saad Eldin, Ibtessam, Achille, Mihaëla, Mueller, Volkmar, Gennari, Alessandra, Cascinu, Stefano, Ghosn, Marwan, El-Saghir, Nagi, Van den Bosch, Joan, Oosterkamp, Rianne, Kukulska, Monika, Pelaez, Ignacio, Hernandez, Carolina, del Mar Gordon, Maria, Dalmau, Elsa, Alonso, Jose Luis, Aksoy, Sercan, Coskun, Hasan Senol, Shparyk, Yaroslav, Varughese, Mohini, Panwar, Udaiveer, Barraclough, Lisa, Levitt, Nicola, Hicks, Jonathan, Rigg, Anna, Allen, Mark, Castillo, Cecila, Fein, Luis Enrique, Stuart-Harris, Robin, Singer, Christian, Stoeger, Herbert, Smiljanic, Sasha, Feng, Jifeng, Cedeño, Miguel, Berdah, Jean Francois, Orfeuvre, Hubert, Goncalves, Anthony, Grischke, Eva-Maria, Simon, Eike, Wagner, Steffen, Efremidou, Anna, Papazisis, Konstantinos, Evron, Ella, Inbar, Moshe, Baruch, Noa Ben, Geffen, David, Karminsky, Natalya, Ruggeri, Enzo Maria, Luigi, Cavanna, Grasso, Donatella, Juozaityte, Elona, Rafael Rodriguez Cid, Jeronimo, Roerdink, Henk, Siddiqi, Neelum, Passos Coelho, José Luís, Garre, Elisa Garcia, Garcia, Andres, Martínez Jañez, Noelia, Lopez Ceballos, Maria Helena, Mele, Mireia, García, María, Arcediano, Alberto, McAdam, Karen, Perren, Timothy, Taylor, Wendy, Humphreys, Alison, Vera, Raul, Kaen, Luis Alberto, Steger, Günther, Andel, Johannes, de Grève, Jacques, Huizing, Manon, Hegg, Roberto, Joy, Anil, Sehdev, Sandeep, Kütner, Riina, Ruohola, Johanna, Dohollou, Nadine, Grosjean, Jessica, Laplaige, Philippe, Largillier, Rémy, Martin, Philippe, Pottier, Virginie, Alexandre, Jerome, Christensen, Bernd, Zahm, Dirk-Michael, Khandan, Fariba, Lueck, Hans-Joachim, Fountzilas, Georgios, Fried, Georgeta, Giacobino, Alice, Bonetti, Andrea, Guerra, Yanin Chavarri, Van Warmerdam, Laurens, Van der Velden, Annette, Vrijaldenhoven, Suzan, de Jongh, Felix, Cavero, Milagros, Andres Conejero, Raquel, Murias, Adolfo, Saura, Salvador, Oltra, Amparo, Redondo, Andres, Ribelles, Nuria, Bachmeier, Kilian, Joffe, Johnathan, Chakraborti, Prabir, Beresford, Mark, Butt, Mohammad, Poole, Christopher, Yordi, Gassan, Woodward, Natasha, Amorim, Gilberto, Califaretti, Nadia, Fox, Susan, Robidoux, Andre, Li, NanLi, Li, Nenxiao, Jiang, Jun, Soria, Tannia, Padrik, Peeter, Saarni, Outi, Genet, Dominique, Catala, Stéphanie, Barletta, Hugues, Teixeira, Luis, Facchini, Thomas, Hesse, Tobias, Kühn, Thorsten, Ober, Angelika, Repp, Roland, Schroeder, Willibald, Pectasides, Dimitrios, Bodoky, Gyorgy, Kahan, Zsuzsanna, Jiveliouk, Irina, Rosengarten, Ora, Alabiso, Oscar, Perez, Mario, Van de Wouw, Yes, Smok-Kalwat, Jolanta, Damasceno, Margarida, Sousa, Gabriela, Abulkhair, Omalkhair, Antón Torres, Antonio, Martinez, Maria Purificación, Garcia Mata, Jesús, Jesús Florián Jerico, Marta Santisteban, Llombart, Antonio, Sanchez, Rosa, Torrego, Juan Carlos, Garate, Clara Olier, Rodriguez, Cesar, Llorente, Rosa, de Prado, Diego Soto, Cortés, Javier, Llorca, Cristina, Galán, Antonio, Viñas Villaro, Gemma, Narbe, Ulrik, Bjömeklett, Helena Granstam, Westwell, Sarah, Newby, Jackie, Jafri, Mariam, Rodríguez, Robinson, Alonso, Isabel, Bachelot, T., Ciruelos, E., Schneeweiss, A., Puglisi, F., Peretz-Yablonski, T., Bondarenko, I., Paluch-Shimon, S., Wardley, A., Merot, J.-L., du Toit, Y., Easton, V., Lindegger, N., and Miles, D.

Published
2019
Full Text
View/download PDF

16. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Author

Sessa, C., Balmaña, J., Bober, S. L., Cardoso, Maria-Joao, Colombo, N., Curigliano, G., Domchek, S. M., Evans, D. G., Fischerova, D., Harbeck, N., Kuhl, C., Lemley, B., Levy-Lahad, E., Lambertini, M., Ledermann, J. A., Loibl, S., Phillips, K.-A., Paluch-Shimon, S., Repositório da Universidade de Lisboa, Sessa, C, Balmana, J, Bober, S, Cardoso, M, Colombo, N, Curigliano, G, Domchek, S, Evans, D, Fischerova, D, Harbeck, N, Kuhl, C, Lemley, B, Levy-Lahad, E, Lambertini, M, Ledermann, J, Loibl, S, Phillips, K, and Paluch-Shimon, S

Subjects
hereditary breast and ovarian cancer syndrome, Oncology, ESMO Clinical Practice Guideline, Hereditary breast and ovarian cancer syndromes, BRCA, Risk reduction, Hematology
Abstract

© 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved

Published
2023

17. P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data

Author

Rotem, O., primary, Peretz, I., additional, Leviov, M., additional, Kuchuk, I., additional, Itay, A., additional, Tokar, M., additional, Paluch-Shimon, S., additional, Maimon, O., additional, Yerushalmi, R., additional, Drumea, K., additional, Evron, E., additional, Sonnenblick, A., additional, Gal-Yam, E., additional, Goldvaser, H., additional, Yosef, S., additional, Merose, R., additional, Bareket-Samish, A., additional, Soussan-Gutman, L., additional, and Stemmer, S.M., additional

Published
2023
Full Text
View/download PDF

19. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Author

Sessa, C., primary, Balmaña, J., additional, Bober, S.L., additional, Cardoso, M.J., additional, Colombo, N., additional, Curigliano, G., additional, Domchek, S.M., additional, Evans, D.G., additional, Fischerova, D., additional, Harbeck, N., additional, Kuhl, C., additional, Lemley, B., additional, Levy-Lahad, E., additional, Lambertini, M., additional, Ledermann, J.A., additional, Loibl, S., additional, Phillips, K.-A., additional, and Paluch-Shimon, S., additional

Published
2023
Full Text
View/download PDF

20. ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

Author

Paluch-Shimon, S., primary, Cardoso, F., additional, Partridge, A.H., additional, Abulkhair, O., additional, Azim, H.A., additional, Bianchi-Micheli, G., additional, Cardoso, M.J., additional, Curigliano, G., additional, Gelmon, K.A., additional, Gentilini, O., additional, Harbeck, N., additional, Kaufman, B., additional, Kim, S.B., additional, Liu, Q., additional, Merschdorf, J., additional, Poortmans, P., additional, Pruneri, G., additional, Senkus, E., additional, Sirohi, B., additional, Spanic, T., additional, Sulosaari, V., additional, Peccatori, F., additional, and Pagani, O., additional

Published
2022
Full Text
View/download PDF

21. Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: disease characteristics and endocrine therapy choice by menopausal status

Author

Lück, HJ, additional, Paluch-Shimon, S, additional, Beith, J, additional, Tokunaga, E, additional, Reyes Contreras, J, additional, Oliveira de Sant’Ana, R, additional, Forrester, T, additional, McNaughton, R, additional, Wei, J, additional, and Harbeck, N, additional

Published
2022
Full Text
View/download PDF

23. 149P Clinical outcomes in ER+ breast cancer patients with recurrence score 26-30-guided therapy: Real-world data

Author

Rotem, O., primary, Peretz, I., additional, Leviov, M., additional, Kuchuk, I., additional, Itay, A., additional, Tokar, M., additional, Paluch-Shimon, S., additional, Maimon, O., additional, Yerushalmi, R., additional, Drumea, K., additional, Evron, E., additional, Sonnenblick, A., additional, Nili Gal Yam, E., additional, Goldvaser, H., additional, Yosef, S.G., additional, Merose, R., additional, Bareket-Samish, A., additional, Soussan-Gutman, L., additional, and Stemmer, S., additional

Published
2022
Full Text
View/download PDF

24. 152P Molecular characterization by the 21-gene breast cancer (BC) Recurrence Score (RS) test of BRCA1/2 mutation carriers (mBRCA1/2) versus the general BC patient (pt) population

Author

Yerushalmi, R., primary, Pomerantz, A., additional, Lewin, R., additional, Paluch-Shimon, S., additional, Soussan-Gutman, L., additional, Baehner, F.L., additional, Voet, H., additional, Bareket-Samish, A., additional, Kedar, I., additional, and Kaduri, L., additional

Published
2022
Full Text
View/download PDF

25. LBA15 MONARCH 3: Interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+, HER2- advanced breast cancer (ABC)

Author

Goetz, M.P., primary, Toi, M., additional, Huober, J., additional, Sohn, J., additional, Tredan, O., additional, Park, I.H., additional, Campone, M., additional, Chen, S.C., additional, Sanchez, L.M. Manso, additional, Paluch-Shimon, S., additional, van Hal, G., additional, Shahir, A., additional, Iwata, H., additional, and Johnston, S., additional

Published
2022
Full Text
View/download PDF

29. 63P Efficacy and safety results by menopausal status in monarchE: Adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2- high-risk early breast cancer

Author

Paluch-Shimon, S., primary, Neven, P., additional, Huober, J., additional, Cicin, I., additional, Jiang, Z., additional, Goetz, M.P., additional, Shimizu, C., additional, Huang, C., additional, Wei, R.J., additional, Nabinger, S.C., additional, Forrester, T., additional, and Harbeck, N., additional

Published
2022
Full Text
View/download PDF

30. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Author

Harbeck, N., primary, Rastogi, P., additional, Martin, M., additional, Tolaney, S.M., additional, Shao, Z.M., additional, Fasching, P.A., additional, Huang, C.S., additional, Jaliffe, G.G., additional, Tryakin, A., additional, Goetz, M.P., additional, Rugo, H.S., additional, Senkus, E., additional, Testa, L., additional, Andersson, M., additional, Tamura, K., additional, Del Mastro, L., additional, Steger, G.G., additional, Kreipe, H., additional, Hegg, R., additional, Sohn, J., additional, Guarneri, V., additional, Cortés, J., additional, Hamilton, E., additional, André, V., additional, Wei, R., additional, Barriga, S., additional, Sherwood, S., additional, Forrester, T., additional, Munoz, M., additional, Shahir, A., additional, San Antonio, B., additional, Nabinger, S.C., additional, Toi, M., additional, Johnston, S.R.D., additional, O’Shaughnessy, J., additional, Jimenez, M.M., additional, Johnston, S., additional, Boyle, F., additional, Neven, P., additional, Jiang, Z., additional, Campone, M., additional, Huober, J., additional, Shimizu, C., additional, Cicin, I., additional, Wardley, A., additional, Abuin, G.G., additional, Zarba, J., additional, Lim, E., additional, Sant, P., additional, Liao, N., additional, Christiansen, B., additional, Eigeliene, N., additional, Martin-Babau, J., additional, Ettl, J., additional, Mavroudis, D., additional, Chiu, J., additional, Boer, K., additional, Nagarkar, R., additional, Paluch-Shimon, S., additional, Moscetti, L., additional, Sagara, Y., additional, Kim, S.-B., additional, Maciel, M.M., additional, Tjan-Heijnen, V., additional, Broom, R., additional, Lacko, A., additional, Schenker, M., additional, Volkov, N., additional, Sim Yap, Y., additional, Coccia-Portugal, M., additional, Ángel García Sáenz, J., additional, Andersson, A., additional, Chao, T.-Y., additional, Gokmen, E., additional, Harputluoglu, H., additional, Berzoy, O., additional, Patt, D., additional, McArthur, H., additional, Chew, H., additional, Chalasani, P., additional, Kaufman, P., additional, Tedesco, K., additional, and Graff, S.L., additional

Published
2021
Full Text
View/download PDF

31. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Author

Gennari, A., primary, André, F., additional, Barrios, C.H., additional, Cortés, J., additional, de Azambuja, E., additional, DeMichele, A., additional, Dent, R., additional, Fenlon, D., additional, Gligorov, J., additional, Hurvitz, S.A., additional, Im, S.-A., additional, Krug, D., additional, Kunz, W.G., additional, Loi, S., additional, Penault-Llorca, F., additional, Ricke, J., additional, Robson, M., additional, Rugo, H.S., additional, Saura, C., additional, Schmid, P., additional, Singer, C.F., additional, Spanic, T., additional, Tolaney, S.M., additional, Turner, N.C., additional, Curigliano, G., additional, Loibl, S., additional, Paluch-Shimon, S., additional, and Harbeck, N., additional

Published
2021
Full Text
View/download PDF

33. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

Author

Miles, D., primary, Ciruelos, E., additional, Schneeweiss, A., additional, Puglisi, F., additional, Peretz-Yablonski, T., additional, Campone, M., additional, Bondarenko, I., additional, Nowecki, Z., additional, Errihani, H., additional, Paluch-Shimon, S., additional, Wardley, A., additional, Merot, J.-L., additional, Trask, P., additional, du Toit, Y., additional, Pena-Murillo, C., additional, Revelant, V., additional, Klingbiel, D., additional, Bachelot, T., additional, Bouzid, K., additional, Desmoulins, I., additional, Coudert, B., additional, Glogowska, I., additional, Ciruelos Gil, E., additional, Dalenc, F., additional, Ricci, F., additional, Dieras, V., additional, Kaufman, B., additional, Ferreira, A., additional, Mano, M., additional, Kalofonos, H., additional, Andreetta, C., additional, Montemurro, F., additional, Barrett, S., additional, Zhang, Q., additional, Mavroudis, D., additional, Matus, J., additional, Villarreal Garza, C., additional, Beato, C., additional, Ismael, G., additional, Hu, X., additional, Abdel Azeem, H., additional, Gaafar, R., additional, Perrin, C., additional, Kerbrat, P., additional, Ettl, J., additional, Paepke, S., additional, Hitre, E., additional, Lang, I., additional, Trudeau, M., additional, Verma, S., additional, Li, H., additional, Hoffmann, O., additional, Aktas, B., additional, Cariello, A., additional, Cruciani, G., additional, Tienghi, A., additional, Tondini, C., additional, Al-Twegieri, T., additional, Loman, N., additional, Laing, R., additional, Miles, D., additional, Brain, E., additional, Fasching, P., additional, Lux, M., additional, Frassoldati, A., additional, Aziz, Z., additional, Salas, J., additional, Streb, J., additional, Krzemieniecki, K., additional, Wronski, A., additional, Garcia Garcia, J., additional, Menjon Beltran, S., additional, Cicin, I., additional, Schmid, P., additional, Gallagher, C., additional, Turner, N., additional, Tong, Z., additional, Boer, K., additional, Juhász, B., additional, Horvath, Z., additional, Bianchini, G., additional, Gianni, L., additional, Curigliano, G., additional, Juarez Ramiro, A., additional, Susnjar, S., additional, Matos, E., additional, Sevillano, E., additional, Garcia Estevez, L., additional, Gokmen, E., additional, Uslu, R., additional, Wildiers, H., additional, Schutz, F., additional, Cruz, M., additional, Bourgeois, H., additional, von Schumann, R., additional, Stemmer, S., additional, Dominguez, A., additional, Morales-Vásques, F., additional, Wojtukiewicz, M., additional, Trifunovic, J., additional, Echarri Gonzalez, M.J., additional, Illarramendi Mañas, J., additional, Martinez De Dueñas, E., additional, Voitko, N., additional, Hicks, J., additional, Waters, S., additional, Barrett-Lee, P., additional, Wheatley, D., additional, De Boer, R., additional, Cocquyt, V., additional, Jerusalem, G., additional, Barrios, C., additional, Panasci, L., additional, Mattson, J., additional, Tanner, M., additional, Gozy, M., additional, Vasilopoulos, G., additional, Papandreou, C., additional, Revesz, J., additional, Battelli, N., additional, Benedetti, G., additional, Latini, L., additional, Gridelli, C., additional, Lazaro Leon, J., additional, Alarcón Company, J., additional, Arance Fernandez, A., additional, Barnadas Molins, A., additional, Calvo Plaza, I., additional, Bratos, R., additional, Gonzalez Martin, A., additional, Izarzugaza Peron, Y., additional, Klint, L., additional, Kovalev, A., additional, McCarthy, N., additional, Yeo, B., additional, Kee, D., additional, Thomson, J., additional, White, S., additional, Greil, R., additional, Wang, S., additional, Artignan, X., additional, Juhasz-Böess, I., additional, Rody, A., additional, Ngan, R., additional, Dourleshter, F., additional, Goldberg, H., additional, Doni, L., additional, Di Costanzo, F., additional, Ferraù, F., additional, Drobniene, M., additional, Aleknavicius, E., additional, Rashid, K., additional, Costa, L., additional, de la Cruz Merino, L., additional, Garcia Saenz, J., additional, López, R., additional, Del Val Munoz, O., additional, Ozyilkan, O., additional, Azribi, F., additional, Jaafar, H., additional, Baird, R., additional, Verrill, M., additional, Beith, J., additional, Petzer, A., additional, Moreira de Andrade, J., additional, Bernstein, V., additional, Macpherson, N., additional, Rayson, D., additional, Saad Eldin, I., additional, Achille, M., additional, Augereau, P., additional, Müller, V., additional, Rasco, A., additional, Evron, E., additional, Katz, D., additional, Berardi, R., additional, Cascinu, S., additional, De Censi, A., additional, Gennari, A., additional, El-Saghir, N., additional, Ghosn, M., additional, Oosterkamp, H.M., additional, Van den Bosch, J., additional, Kukulska, M., additional, Kalinka, E., additional, Alonso, J., additional, Dalmau Portulas, E., additional, Del Mar Gordon Santiago, M., additional, Pelaez Fernandez, I., additional, Aksoy, S., additional, Altundag, K., additional, Senol Coskun, H., additional, Bozcuk, H., additional, Shparyk, Y., additional, Barraclough, L., additional, Levitt, N., additional, Panwar, U., additional, Kelly, S., additional, Rigg, A., additional, Varughese, M., additional, Castillo, C., additional, Fein, L., additional, Malik, L., additional, Stuart-Harris, R., additional, Singer, C., additional, Stoeger, H., additional, Samonigg, H., additional, Feng, J., additional, Cedeño, M., additional, Ruohola, J., additional, Berdah, J.-F., additional, Goncalves, A., additional, Orfeuvre, H., additional, Grischke, E.-M., additional, Simon, E., additional, Wagner, S., additional, Koumakis, G., additional, Papazisis, K., additional, Ben Baruch, N., additional, Fried, G., additional, Geffen, D., additional, Karminsky, N., additional, Peretz, T., additional, Cavanna, L., additional, Pedrazzioli, P., additional, Grasso, D., additional, Ruggeri, E., additional, D’Auria, G., additional, Moscetti, L., additional, Juozaityte, E., additional, Rodriguez Cid, J., additional, Roerdink, H., additional, Siddiqi, N., additional, Passos Coelho, J., additional, Arcediano Del Amo, A., additional, Garcia Garre, E., additional, García Gonzalez, M., additional, Garcia-Palomo Perez, A., additional, Herenandez Perez, C., additional, Lopez Alvarez, P., additional, Lopez De Ceballos, M.H., additional, Martínez Jañez, N., additional, Mele Olive, M., additional, McAdam, K., additional, Perren, T., additional, Dunn, G., additional, Humphreys, A., additional, Taylor, W., additional, Vera, R., additional, Kaen, L., additional, Andel, J., additional, Steger, G., additional, De Grève, J., additional, Huizing, M., additional, Hegg, R., additional, Joy, A., additional, Kuruvilla, P., additional, Sehdev, S., additional, Smiljanic, S., additional, Kütner, R., additional, Alexandre, J., additional, Grosjean, J., additional, Laplaige, P., additional, Largillier, R., additional, Maes, P., additional, Martin, P., additional, Pottier, V., additional, Christensen, B., additional, Khandan, F., additional, Lück, H.-J., additional, Zahm, D.-M., additional, Fountzilas, G., additional, Karavasilis, V., additional, Safra, T., additional, Inbar, M., additional, Ryvo, L., additional, Bonetti, A., additional, Seles, E., additional, Giacobino, A., additional, Chavarri Guerra, Y., additional, de Jongh, F., additional, van der Velden, A., additional, van Warmerdam, L., additional, Vrijaldenhoven, S., additional, Smorenburg, C.H., additional, Cavero, M., additional, Andres Conejero, R., additional, Oltra Ferrando, A., additional, Redondo Sanchez, A., additional, Ribelles Entrena, N., additional, Saura Grau, S., additional, Viñas Vilaro, G., additional, Bachmeier, K., additional, Beresford, M., additional, Butt, M., additional, Joffe, J., additional, Poole, C., additional, Woodings, P., additional, Chakraborti, P., additional, Yordi, G., additional, Woodward, N., additional, Nobre, A., additional, Luiz Amorim, G., additional, Califaretti, N., additional, Fox, S., additional, Robidoux, A., additional, Li, E., additional, Li, N., additional, Jiang, J., additional, Soria, T., additional, Padrik, P., additional, Lahdenpera, O., additional, Barletta, H., additional, Dohollou, N., additional, Genet, D., additional, Prulhiere, K., additional, Coeffic, D., additional, Facchini, T., additional, Vieillot, S., additional, Catala, S., additional, Teixeira, L., additional, Hesse, T., additional, Kühn, T., additional, Ober, A., additional, Repp, R., additional, Schröder, W., additional, Pectasides, D., additional, Bodoky, G., additional, Kahan, Z., additional, Jiveliouk, I., additional, Rosengarten, O., additional, Rossi, V., additional, Alabiso, O., additional, Pérez Martínez, M., additional, van de Wouw, A.J., additional, Smok-Kalwat, J., additional, Damasecno, M., additional, Augusto, I., additional, Sousa, G., additional, Saadein, A., additional, Abdelhafiez, N., additional, Abulkhair, O., additional, Antón Torres, A., additional, Corbellas Aparicio, M., additional, Llorente Domenech, R., additional, Florián Jerico, J., additional, Garcia Mata, J., additional, Gil Raga, M., additional, Galan Brotons, A., additional, Llombart Cussac, A., additional, Llorca Ferrandiz, C., additional, Martinez Del Prado, P., additional, Olier Garate, C., additional, Rodriguez Sanchez, C., additional, Sanchez Gomez, R., additional, Santisteban Eslava, M., additional, Soberino, J., additional, Vidal Losada Garcia, M., additional, Soto de Prado, D., additional, Torrego Garcia, J., additional, Vicente Rubio, E., additional, Garcia, M., additional, Murias Rosales, A., additional, Granstam Björneklett, H., additional, Narbe, U., additional, Jafri, M., additional, Rea, D., additional, Newby, J., additional, Jones, A., additional, Westwell, S., additional, Ring, A., additional, Alonso, I., additional, and Rodríguez, R., additional

Published
2021
Full Text
View/download PDF

34. 153P Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausal status

Author

Paluch-Shimon, S., primary, Lueck, H., additional, Beith, J., additional, Tokunaga, E., additional, Contreras, J. Reyes, additional, de Sant’Ana, R.O., additional, Forrester, T., additional, McNaughton, R., additional, Wei, J., additional, and Harbeck, N., additional

Published
2021
Full Text
View/download PDF

35. Final results from PERUSE, a global study of pertuzumab (P), trastuzumab (H) and investigator’s chosen taxane as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)

Author

Schneeweiss, A, additional, Miles, D, additional, Ciruelos, E, additional, Puglisi, F, additional, Peretz-Yablonski, T, additional, Campone, M, additional, Bondarenko, I, additional, Nowecki, Z, additional, Errihani, H, additional, Paluch-Shimon, S, additional, Wardley, A, additional, Merot, J-L, additional, du Toit, Y, additional, Klingbiel, D, additional, Revelant, V, additional, and Bachelot, T, additional

Published
2021
Full Text
View/download PDF

36. Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

Author

UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, Condorelli, M, Bruzzone, M, Ceppi, M, Ferrari, A, Grinshpun, A, Hamy, A S, de Azambuja, E, Carrasco, E, Peccatori, F A, Di Meglio, A, Paluch-Shimon, S, Poorvu, P D, Venturelli, M, Rousset-Jablonski, C, Senechal, C, Livraghi, L, Ponzone, R, De Marchis, L, Pogoda, K, Sonnenblick, A, Villarreal-Garza, C, Córdoba, O, Teixeira, L, Clatot, F, Punie, K, Graffeo, R, Dieci, M V, Pérez-Fidalgo, J A, Duhoux, Francois, Puglisi, F, Ferreira, A R, Blondeaux, E, Peretz-Yablonski, T, Caron, O, Saule, C, Ameye, L, Balmaña, J, Partridge, A H, Azim, H A, Demeestere, I, Lambertini, M, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, Condorelli, M, Bruzzone, M, Ceppi, M, Ferrari, A, Grinshpun, A, Hamy, A S, de Azambuja, E, Carrasco, E, Peccatori, F A, Di Meglio, A, Paluch-Shimon, S, Poorvu, P D, Venturelli, M, Rousset-Jablonski, C, Senechal, C, Livraghi, L, Ponzone, R, De Marchis, L, Pogoda, K, Sonnenblick, A, Villarreal-Garza, C, Córdoba, O, Teixeira, L, Clatot, F, Punie, K, Graffeo, R, Dieci, M V, Pérez-Fidalgo, J A, Duhoux, Francois, Puglisi, F, Ferreira, A R, Blondeaux, E, Peretz-Yablonski, T, Caron, O, Saule, C, Ameye, L, Balmaña, J, Partridge, A H, Azim, H A, Demeestere, I, and Lambertini, M

Abstract

Knowledge is growing on the safety of assisted reproductive techniques (ART) in cancer survivors. No data exist, however, for the specific population of breast cancer patients harboring germline BRCA1/2 pathogenic variants. This is a multicenter retrospective cohort study across 30 centers worldwide including women diagnosed at ≤40 years with stage I-III breast cancer, between January 2000 and December 2012, harboring known germline BRCA1/2 pathogenic variants. Patients included in this analysis had a post-treatment pregnancy either achieved through use of ART (ART group) or naturally (non-ART group). ART procedures included ovulation induction, ovarian stimulation for in vitro fertilization or intracytoplasmic sperm injection, and embryo transfer under hormonal replacement therapy. Among the 1424 patients registered in the study, 168 were eligible for inclusion in the present analysis, of whom 22 were in the ART group and 146 in the non-ART group. Survivors in the ART group conceived at an older age compared with those in the non-ART group (median age: 39.7 versus 35.4 years, respectively). Women in the ART group experienced more delivery complications compared with those in the non-ART group (22.1% versus 4.1%, respectively). No other apparent differences in obstetrical outcomes were observed between cohorts. The median follow-up from pregnancy was 3.4 years (range: 0.8-8.6 years) in the ART group and 5.0 years (range: 0.8-17.6 years) in the non-ART group. Two patients (9.1%) in the ART group experienced a disease-free survival event (specifically, a locoregional recurrence) compared with 40 patients (27.4%) in the non-ART group. In the ART group, no patients deceased compared with 10 patients (6.9%) in the non-ART group. This study provides encouraging safety data on the use of ART in breast cancer survivors harboring germline pathogenic variants in BRCA1/2, when natural conception fails or when they opt for ART in order to carry out preimplantation genetic testi

Published
2021

37. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Author

F, CARDOSO, Paluch-Shimon, S, Senkus, E, Curigliano, G, Aapro, M S, F, ANDE, C H, BARRIOS, J, BERGH, Bhattacharyya, G S, Biganzoli, L, F, BOYLE, CARDOSO, M-J, L A, CAREY, J, CORTES, EL SAGHIR, N S, M, ELZAYAT, A, ENIU, L, FALLOWFIED, P A, FRANCIS, Gelmon, K, Gligorov, J, R, HAIDINGER, Harbeck, N, X, HU, Kaufman, B, Kaur, R., B E, KIELY, S-B, KIM, N U, LIN, S A, MERTZ, S, NECIOSUP, Offersen, BV, S, OHNO, O, PAGANI, A, PRAT, Penault-Llorca, F, Rugo, HS, Sledge, GW, Thomssen, C, Vorobiof, DA, Wiseman, T., B, XU, Norton, L, A, COSTA, Winer, EP, Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), and UNICANCER

Subjects
0303 health sciences, [SDV]Life Sciences [q-bio], COVID-19, Hematology, 3. Good health, metastatic, Coronavirus, 03 medical and health sciences, Special Article, 0302 clinical medicine, breast cancer, Oncology, advanced, ESO-ESMO, 030220 oncology & carcinogenesis, guidelines, skin and connective tissue diseases, ABC, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology
Abstract

Highlights • This ESO-ESMO ABC 5 Clinical Practice Guideline provides key recommendations for managing advanced breast cancer patients • It provides updates on the management of patients with all breast cancer subtypes, LABC, follow-up, palliative and supportive care • Updated diagnostic and treatment algorithms are also provided • All recommendations were compiled by a multidisciplinary group of international experts • Recommendations are based on available clinical evidence and the collective expert opinion of the authors

Published
2020

39. ESMO Guidelines: Cancer patient management during the COVID-19 pandemic

Author

Aapro, M., Addeo, A., Acierto, P., Balermpas, P., Berg, T., Berghoff, A., Betella, I., Blay, J. -Y., Bosetti, D. G., Bossi, P., Bouchaab, H., Brandt, J., Buske, C., Caraceni, A., Cardoso, F., Carles, J., Catanese, S., Cherny, N., Colombo, I., Colombo, N., Cortes, J., Criscitiello, C., Curigliano, G., de Azambuja, E., Delagoge, S., Del Grande, M., De Santis, M., Douillard, J. -Y., Dummer, R., Dziadziuszko, R., Escudier, B., Fizazi, K., Fleitas, T., Franceschi, E., Hoeller, C., Gillessen, S., Gonzalez Martin, A., Gralla, R., Grigorescu, A., Gronchi, A., Hassan, A., Hui, D., Jerkeman, M., Jones, R., Jordan, K., Keilholz, U., Kreye, G., Ledermann, J., Loibl, S., Lordick, F., Lorigan, P., Loriot, Y., Machiels, J. -P., Broto, J. M., Mei, U., Michielin, O., Mori, M., Multinu, F., Paluch-Shimon, S., Parker, C., Passaro, A., Pentheroudakis, G., Peters, S., Piazza, C., Porta, C., Powles, T., Preusser, M., Reck, M., Ripamonti, C., Rubach, M., Rukhadze, T., Schmidinger, M., Sensus-Konefka, E., Sessa, C., Shaulov, A., Stacchiotti, S., Stevens, A. -M., Stintzing, S., Szturz, P., Trapani, D., van Akkooi, A., Vecchione, L., van Bommel, F., Vogl, U., Von Garnier, C., Weller, M., Wood, J., Zaccarelli, E., and Zimmermann, C.

Published
2020

40. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Author

Cardoso, F, Paluch-Shimon, S, Senkus, E, Curigliano, G, Aapro, MS, Andre, F, Barrios, CH, Bergh, J, Bhattacharyya, GS, Biganzoli, L, Boyle, F, Cardoso, M-J, Carey, LA, Cortes, J, El Saghir, NS, Elzayat, M, Eniu, A, Fallowfield, L, Francis, PA, Gelmon, K, Gligorov, J, Haidinger, R, Harbeck, N, Hu, X, Kaufman, B, Kaur, R, Kiely, BE, Kim, S-B, Lin, NU, Mertz, SA, Neciosup, S, Offersen, B, Ohno, S, Pagani, O, Prat, A, Penault-Llorca, F, Rugo, HS, Sledge, GW, Thomssen, C, Vorobiof, DA, Wiseman, T, Xu, B, Norton, L, Costa, A, Winer, EP, Cardoso, F, Paluch-Shimon, S, Senkus, E, Curigliano, G, Aapro, MS, Andre, F, Barrios, CH, Bergh, J, Bhattacharyya, GS, Biganzoli, L, Boyle, F, Cardoso, M-J, Carey, LA, Cortes, J, El Saghir, NS, Elzayat, M, Eniu, A, Fallowfield, L, Francis, PA, Gelmon, K, Gligorov, J, Haidinger, R, Harbeck, N, Hu, X, Kaufman, B, Kaur, R, Kiely, BE, Kim, S-B, Lin, NU, Mertz, SA, Neciosup, S, Offersen, B, Ohno, S, Pagani, O, Prat, A, Penault-Llorca, F, Rugo, HS, Sledge, GW, Thomssen, C, Vorobiof, DA, Wiseman, T, Xu, B, Norton, L, Costa, A, and Winer, EP

Published
2020

41. 288P Final results from PERUSE, a global study of pertuzumab (P), trastuzumab (H) and investigator’s chosen taxane as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)

Author

Miles, D.W., primary, Ciruelos, E.M., additional, Schneeweiss, A., additional, Puglisi, F., additional, Peretz-Yablonski, T., additional, Campone, M., additional, Bondarenko, I., additional, Nowecki, Z., additional, Errihani, H., additional, Paluch-Shimon, S., additional, Wardley, A.M., additional, Merot, J.L., additional, du Toit, Y., additional, Klingbiel, D., additional, Revelant, V., additional, and Bachelot, T., additional

Published
2020
Full Text
View/download PDF

42. Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Author

Hortobagyi, G.N., primary, Stemmer, S.M., additional, Burris, H.A., additional, Yap, Y.S., additional, Sonke, G.S., additional, Paluch-Shimon, S., additional, Campone, M., additional, Petrakova, K., additional, Blackwell, K.L., additional, Winer, E.P., additional, Janni, W., additional, Verma, S., additional, Conte, P., additional, Arteaga, C.L., additional, Cameron, D.A., additional, Mondal, S., additional, Su, F., additional, Miller, M., additional, Elmeliegy, M., additional, Germa, C., additional, and O’Shaughnessy, J., additional

Published
2019
Full Text
View/download PDF

43. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

Author

Cardoso, F, Senkus, E., Costa, A, Papadopoulos, E, Aapro, M, André, F, Harbeck, N, Aguilar Lopez, B, Barrios, CH, Bergh, J, Prat, A, Boers-Doets, CB, Cardoso, MJ, Carey, LA, Cortés, J, Curigliano, G, Diéras, V, Saghir NS, EL, Eniu, A, Fallowfield, L, Francis, PA, Gelmon, K, Johnston, SRD, Kaufman, B, Koppikar, S, Krop, IE, Mayer, M, Nakigudde, G, Offersen, BV, Ohno, S, Pagani, O, Paluch-Shimon, S, Penault-Llorca, F, Prat, A., Rugo, HS, Sledge, GW, Spence, D, Thomssen, C, Vorobiof, DA, Xu, B., Norton, L, Winer, EP, Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland, Medical University of Gdansk, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Imagerie Moléculaire et Stratégies Théranostiques (IMoST), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])

Subjects
0301 basic medicine, Consensus Development Conferences as Topic, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Medical Oncology, 03 medical and health sciences, 0302 clinical medicine, Biomarkers, Tumor, Humans, Breast, Mastectomy, Societies, Medical, ComputingMilieux_MISCELLANEOUS, Neoplasm Staging, Clinical Trials as Topic, Integrative Medicine, Evidence-Based Medicine, Hematology, Chemoradiotherapy, Adjuvant, Neoadjuvant Therapy, 3. Good health, Europe, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Special article, Female, Biopsy, Large-Core Needle
Abstract

International audience

Published
2018

44. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Author

Bachelot, T., primary, Ciruelos, E., additional, Schneeweiss, A., additional, Puglisi, F., additional, Peretz-Yablonski, T., additional, Bondarenko, I., additional, Paluch-Shimon, S., additional, Wardley, A., additional, Merot, J.-L., additional, du Toit, Y., additional, Easton, V., additional, Lindegger, N., additional, Miles, D., additional, Bouzid, Kamel, additional, Campone, Mario, additional, Coudert, Bruno, additional, Nowecki, Zbigniew, additional, Errihani, Hassan, additional, Dalenc, Florence, additional, Ferreira, Ana, additional, Mano, Max, additional, Ricci, Francesco, additional, Kalofonos, Haralabos, additional, Andreetta, Claudia, additional, Montemurro, Filippo, additional, Barrett, Sophie, additional, Zhang, Qingyuan, additional, Mavroudis, Dimitris, additional, Matus, Juan, additional, Beato, Carlos, additional, Hu, Xichun, additional, Gaafar, Rabab, additional, Abdel Azeem, Hamdy, additional, Perrin, Christophe, additional, Ettl, Johannes, additional, Lang, Istvan, additional, Verma, Sunil, additional, Li, Huiping, additional, Brain, Etienne, additional, Hoffmann, Oliver, additional, Cariello, Anna, additional, Tondini, Carlo, additional, Altwegeiri, Taher, additional, Loman, Niklas, additional, Lux, Michael, additional, Frassoldati, Antonio, additional, Aziz, Zeba, additional, Salas, Fernando, additional, Streb, Joanna, additional, Wronski, Andrzej, additional, Menjón Beltrán, Salomón, additional, Cicin, Irfan, additional, Schmid, Peter, additional, Laing, Robert, additional, Tong, Zhongsheng, additional, Boer, Katalin, additional, Juhasz, Balazs, additional, Gianni, Luca, additional, Curigliano, Giuseppe, additional, Juarez, Alejandro, additional, Susnjar, Snezana, additional, Matos, Erika, additional, Uslu, Ruchan, additional, Wildiers, Hans, additional, Cruz, Marcelo, additional, Bourgeois, Hugues, additional, von Schumann, Raquel, additional, Stemmer, Salomón, additional, Vásquez, Flavia Morales, additional, Dominguez, Adriana, additional, Wojtukiewicz, Marek, additional, Trifunovic, Jasna, additional, Illarramendi, Jose Juan, additional, Garcia, Laura, additional, Peron, Yann Izarzugaza, additional, Echarri, Maria Jose, additional, Voitko, Natliia, additional, Wheatley, Duncan, additional, Waters, Simon, additional, De Boer, Richard, additional, Jerusalem, Guy, additional, Cocquyt, Véronique, additional, Barrios, Carlos, additional, Panasci, Lawrence, additional, Mattson, Johanna, additional, Tanner, Minna, additional, Gozy, Michel, additional, Vasilopoulos, Georgios, additional, Revesz, Janos, additional, Latini, Luciano, additional, Gridelli, Cesare, additional, Lazaro, Jesus, additional, Gonzalez, Antonio, additional, Barnadas Molins, Agusti, additional, Martinez, Eduardo, additional, Alarcón, Jesús, additional, Arance, Ana, additional, Klint, Leif, additional, Kovalyov, Oleksiy, additional, Baird, Richard, additional, Yeo, Belinda, additional, McCarthy, Nicole, additional, Greil, Richard, additional, Wang, Shusen, additional, Artignan, Xavier, additional, Augereau, Paule, additional, Juhasz-Boess, Ingolf, additional, Ngan, Roger, additional, Goldberg, Hadassah, additional, Di Costanzo, Francesco, additional, Ferraù, Francesco, additional, Aleknavicius, Eduardas, additional, Rashid, Kamran, additional, Costa, Luís, additional, Angel Garcia, Jose, additional, de la Cruz, Luis Ruiz, additional, López López, Rafael, additional, Del Val, Olga, additional, Ozyilkan, Ozgur, additional, Azribi, Fathi, additional, Verrill, Mark, additional, Turner, Nicholas, additional, Beith, Jane, additional, Petzer, Andreas, additional, Andrade, Jurandyr, additional, Bernstein, Vanessa, additional, Rayson, Daniel, additional, Saad Eldin, Ibtessam, additional, Achille, Mihaëla, additional, Mueller, Volkmar, additional, Gennari, Alessandra, additional, Cascinu, Stefano, additional, Ghosn, Marwan, additional, El-Saghir, Nagi, additional, Van den Bosch, Joan, additional, Oosterkamp, Rianne, additional, Kukulska, Monika, additional, Pelaez, Ignacio, additional, Hernandez, Carolina, additional, del Mar Gordon, Maria, additional, Dalmau, Elsa, additional, Alonso, Jose Luis, additional, Aksoy, Sercan, additional, Coskun, Hasan Senol, additional, Shparyk, Yaroslav, additional, Varughese, Mohini, additional, Panwar, Udaiveer, additional, Barraclough, Lisa, additional, Levitt, Nicola, additional, Hicks, Jonathan, additional, Rigg, Anna, additional, Allen, Mark, additional, Castillo, Cecila, additional, Fein, Luis Enrique, additional, Stuart-Harris, Robin, additional, Singer, Christian, additional, Stoeger, Herbert, additional, Smiljanic, Sasha, additional, Feng, Jifeng, additional, Cedeño, Miguel, additional, Berdah, Jean Francois, additional, Orfeuvre, Hubert, additional, Goncalves, Anthony, additional, Grischke, Eva-Maria, additional, Simon, Eike, additional, Wagner, Steffen, additional, Efremidou, Anna, additional, Papazisis, Konstantinos, additional, Evron, Ella, additional, Inbar, Moshe, additional, Baruch, Noa Ben, additional, Geffen, David, additional, Karminsky, Natalya, additional, Ruggeri, Enzo Maria, additional, Luigi, Cavanna, additional, Grasso, Donatella, additional, Juozaityte, Elona, additional, Rafael Rodriguez Cid, Jeronimo, additional, Roerdink, Henk, additional, Siddiqi, Neelum, additional, Passos Coelho, José Luís, additional, Garre, Elisa Garcia, additional, Garcia, Andres, additional, Martínez Jañez, Noelia, additional, Lopez Ceballos, Maria Helena, additional, Mele, Mireia, additional, García, María, additional, Arcediano, Alberto, additional, McAdam, Karen, additional, Perren, Timothy, additional, Taylor, Wendy, additional, Humphreys, Alison, additional, Vera, Raul, additional, Kaen, Luis Alberto, additional, Steger, Günther, additional, Andel, Johannes, additional, de Grève, Jacques, additional, Huizing, Manon, additional, Hegg, Roberto, additional, Joy, Anil, additional, Sehdev, Sandeep, additional, Kütner, Riina, additional, Ruohola, Johanna, additional, Dohollou, Nadine, additional, Grosjean, Jessica, additional, Laplaige, Philippe, additional, Largillier, Rémy, additional, Martin, Philippe, additional, Pottier, Virginie, additional, Alexandre, Jerome, additional, Christensen, Bernd, additional, Zahm, Dirk-Michael, additional, Khandan, Fariba, additional, Lueck, Hans-Joachim, additional, Fountzilas, Georgios, additional, Fried, Georgeta, additional, Giacobino, Alice, additional, Bonetti, Andrea, additional, Guerra, Yanin Chavarri, additional, Van Warmerdam, Laurens, additional, Van der Velden, Annette, additional, Vrijaldenhoven, Suzan, additional, de Jongh, Felix, additional, Cavero, Milagros, additional, Andres Conejero, Raquel, additional, Murias, Adolfo, additional, Saura, Salvador, additional, Oltra, Amparo, additional, Redondo, Andres, additional, Ribelles, Nuria, additional, Bachmeier, Kilian, additional, Joffe, Johnathan, additional, Chakraborti, Prabir, additional, Beresford, Mark, additional, Butt, Mohammad, additional, Poole, Christopher, additional, Yordi, Gassan, additional, Woodward, Natasha, additional, Amorim, Gilberto, additional, Califaretti, Nadia, additional, Fox, Susan, additional, Robidoux, Andre, additional, Li, NanLi, additional, Li, Nenxiao, additional, Jiang, Jun, additional, Soria, Tannia, additional, Padrik, Peeter, additional, Saarni, Outi, additional, Genet, Dominique, additional, Catala, Stéphanie, additional, Barletta, Hugues, additional, Teixeira, Luis, additional, Facchini, Thomas, additional, Hesse, Tobias, additional, Kühn, Thorsten, additional, Ober, Angelika, additional, Repp, Roland, additional, Schroeder, Willibald, additional, Pectasides, Dimitrios, additional, Bodoky, Gyorgy, additional, Kahan, Zsuzsanna, additional, Jiveliouk, Irina, additional, Rosengarten, Ora, additional, Alabiso, Oscar, additional, Perez, Mario, additional, Van de Wouw, Yes, additional, Smok-Kalwat, Jolanta, additional, Damasceno, Margarida, additional, Sousa, Gabriela, additional, Abulkhair, Omalkhair, additional, Antón Torres, Antonio, additional, Martinez, Maria Purificación, additional, Garcia Mata, Jesús, additional, Jesús Florián Jerico, Marta Santisteban, additional, Llombart, Antonio, additional, Sanchez, Rosa, additional, Torrego, Juan Carlos, additional, Garate, Clara Olier, additional, Rodriguez, Cesar, additional, Llorente, Rosa, additional, de Prado, Diego Soto, additional, Cortés, Javier, additional, Llorca, Cristina, additional, Galán, Antonio, additional, Viñas Villaro, Gemma, additional, Narbe, Ulrik, additional, Bjömeklett, Helena Granstam, additional, Westwell, Sarah, additional, Newby, Jackie, additional, Jafri, Mariam, additional, Rodríguez, Robinson, additional, and Alonso, Isabel, additional

Published
2019
Full Text
View/download PDF

45. Physicians’ knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey

Author

Lambertini, M., primary, Di Maio, M., additional, Poggio, F., additional, Pagani, O., additional, Curigliano, G., additional, Del Mastro, L., additional, Paluch-Shimon, S., additional, Loibl, S., additional, Partridge, A.H., additional, Azim, H.A., additional, Peccatori, F.A., additional, and Demeestere, I., additional

Published
2018
Full Text
View/download PDF

46. Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Author

Hortobagyi, G.N., primary, Stemmer, S.M., additional, Burris, H.A., additional, Yap, Y.S., additional, Sonke, G.S., additional, Paluch-Shimon, S., additional, Campone, M., additional, Petrakova, K., additional, Blackwell, K.L., additional, Winer, E.P., additional, Janni, W., additional, Verma, S., additional, Conte, P., additional, Arteaga, C.L., additional, Cameron, D.A., additional, Mondal, S., additional, Su, F., additional, Miller, M., additional, Elmeliegy, M., additional, Germa, C., additional, and O’Shaughnessy, J., additional

Published
2018
Full Text
View/download PDF

47. The BCY3/BCC 2017 survey on physicians’ knowledge, attitudes and practice towards fertility and pregnancy issues in young breast cancer patients

Author

Lambertini, M., primary, Di Maio, M., additional, Pagani, O., additional, Curigliano, G., additional, Poggio, F., additional, Del Mastro, L., additional, Paluch-Shimon, S., additional, Loibl, S., additional, Partridge, A.H., additional, Azim, H.A., additional, Demeestere, I., additional, and Peccatori, F.A., additional

Published
2018
Full Text
View/download PDF

48. Abstract P5-21-18: Subsequent treatment for postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer who received ribociclib + letrozole vs placebo + letrozole in the phase III MONALEESA-2 study

Author

Blackwell, KL, primary, Paluch-Shimon, S, additional, Campone, M, additional, Conte, P, additional, Petrakova, K, additional, Favret, A, additional, Blau, S, additional, Beck, JT, additional, Miller, M, additional, Sutradhar, S, additional, Monaco, M, additional, and Burris, HA, additional

Published
2018
Full Text
View/download PDF

49. Abstract PD4-06: First-line ribociclib + letrozole in hormone receptor-positive, HER2-negative advanced breast cancer: Efficacy by baseline circulating tumor DNA alterations in MONALEESA-2

Author

Hortobagyi, GN, primary, Stemmer, S, additional, Campone, M, additional, Sonke, GS, additional, Arteaga, CL, additional, Paluch-Shimon, S, additional, Petrakova, K, additional, Villanueva, C, additional, Nusch, A, additional, Grischke, E-M, additional, Chan, A, additional, Jakobsen, E, additional, Marschner, N, additional, Hart, LL, additional, Alba, E, additional, Ohnstand, HO, additional, Blau, S, additional, Yardley, DA, additional, Solovieff, N, additional, Su, F, additional, Germa, C, additional, and Yap, Y-S, additional

Published
2018
Full Text
View/download PDF

50. MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer

Author

Di Leo, A., primary, Toi, M., additional, Campone, M., additional, Sohn, J., additional, Paluch-Shimon, S., additional, Huober, J., additional, Park, I.H., additional, Tredan, O., additional, Chen, S-C., additional, Manso, L., additional, Freedman, O., additional, Jaliffe, G.G., additional, Forrester, T., additional, Frenzel, M., additional, Barriga, S., additional, Smith, I.C., additional, Bourayou, N., additional, and Goetz, M.P., additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results